Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients

British Journal of Cancer

Volumn 80, Issue 11, 1999, Pages 1803-1808

  Hickey, K P ^a   Boyle, K P ^b   Jepps, H M ^b   Andrew, A C ^b   Buxton, E J ^a   Burns, P A ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Microsatellite instabiliry; Molecular detection; Ovarian cancer; Serum

Indexed keywords

DNA; MICROSATELLITE DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE INSTABILITY; OVARY CANCER; PERITONEAL FLUID; PRIORITY JOURNAL; SERUM;

ALLELES; ASCITIC FLUID; DNA, NEOPLASM; FEMALE; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 0032774750     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690601     Document Type: Article

References (29)

1. Berek JS (1994) Epithelial ovarian cancer. In: Practical Gynaecological Oncology, 2nd edn, Berek JS, Hacker NF (eds), pp. 327-375. Williams and Wilkins: Baltimore
2. Bicknell DC, Kaklamanis L, Hampson R, Bodmer WF and Karran P (1996) Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 6: 1695-1697
3. Caldas C (1997) Molecular staging of cancer: is it time? Lancet 350: 231
4. Cawkwell L, Lewis FA and Quirke P (1994) Frequency of allele loss of DCC, p53. RB1, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70: 813-818
5. Chen XQ, Stroun M, Magnenat JL, Nicod LP, Kurt AM, Lyautey J, Lederrey C and Anker P (1996) Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2: 1033-1035
6. Cliby W, Ritland S, Hartmann L, Dodson M, Halling KC, Keeney G, Podratz KC and Jenkins RB (1993) Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393-2398
7. Droegemueller W (1994) Screening for ovarian carcinoma: hopeful and wishful thinking. Am J Obstet Gynecol 170: 1095-1098
8. Fujita M, Enomoto T, Yoshino K, Nomura T, Buzard GS, Inoue M and Okudaira Y (1995) Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int J Cancer 63: 361-366
9. Gallion HH, Pieretti M, DePriest PD and van Nagell JR (1995) The molecular basis of ovarian cancer. Cancer 76: 1992-1997
10. Gao X, Zacharek A, Salkowski A, Grignon DJ, Saki W, Porter AT and Honn KV (1995) Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55: 1002-1005
11. Gyapay G, Morissetle J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nat Genet 7: 246-339
12. Hibi K, Robinson CR, Booker S, Wu L, Hamilton SR, Sidransky D and Jen J (1998) Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405-1407
13. King BL, Carcangiu ML, Carter D, Kiechle M, Pfisterer J, Pffeiderer A and Kacinski BM (1995) Microsatellite instability in ovarian neoplasms. Br J Cancer 72: 376-382
14. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahli M, Pylkkanen L, Heimdal K, Andersen TI, Moller P, Rognum TO, et al. (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849-5852
15. Lukish JR, Muro K, DeNobile J, Katz R, Williams J, Cruess DF, Drucker W, Kirsch T and Hamilton SR (1998) Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227: 51-56
16. Mao L, Hruban RH, Boyle JO, Tockman M and Sidransky D (1994) Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54: 1634-1637
17. Mao L, Schoenberg MP, Scicchitano M, Erozan YS, Merlo A, Schwab D and Sidransky D (1996) Molecular detection of primary bladder cancer by microsatellite analysis. Science 271: 659-662
18. Nawroz H, Koch W, Anker P, Stroun M and Sidransky D (1996) Microsatellite alterations in serum DNA of head ami neck cancer patients. Nat Med 2: 1035-1037
19. Osborne RJ and Leech V (1994) Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69: 429-438
20. Phillips N, Ziegler M, Saha B and Xynos F (1993) Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 54: 85-91
21. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RF, Hamilton TC and Godwin AK (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p. including CDKN2. Cancer Res 55: 2150-2157
22. Sidransky D, Tokino T, Hamilton SR, Kinzler KW, Levin B, Frost P and Vogelstein B (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105
23. Skates SJ, Xu FJ, Yu YH, Sjovall K, Einhorn N, Chang YC, Bast RC and Knapp RC (1995) Toward an optimal algorithm for ovarian-cancer screening with longitudinal tumor-markers. Cancer 76: 2004-2010
24. Smith B, Selby P, Southgate J, Pittman K, Bradley C and Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338. 1227-1229
25. Sood AK and Buller RE (1996) Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 13: 2499-2504
26. Spirio L, Nelson L, Ward K, Burt R, White R and Leppert M (1993) A CA repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 52: 286-296
27. van Nagell JR, Jr, Gallion HH, Paslik EJ and DePriest PD (1995) Ovarian cancer screening. Cancer 76: 2086-2091
28. Woolas RP, Xu FJ, Jacobs IJ, Yu YH, Daly L, Berchuck A, Soper JT, Clarke-Pearson DL, Oram DH and Bast RC (1993) Elevation of multiple scrum markers in patients with stage 1 ovarian cancer. J Natl Cancer Inst 85: 1748-1751
29. Zenklusen JC, Weitzel JN, Ball HG and Conti CJ (1995) Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor-suppressor gene. Oncogene 11: 359-363